Company Registration No. 03688753 (England and Wales)
Lisoma International Limited
Unaudited accounts
for the year ended 31 December 2025
Lisoma International Limited
Unaudited accounts
Contents
Lisoma International Limited
Company Information
for the year ended 31 December 2025
Director
K L Aspinall Nessling
Company Number
03688753 (England and Wales)
Registered Office
14 Whyke Road
Chichester
PO19 7AN
England
Lisoma International Limited
Statement of financial position
as at 31 December 2025
Cash at bank and in hand
10,330
205,202
Creditors: amounts falling due within one year
(418,189)
(188,981)
Net current assets
182,175
230,857
Net assets
182,420
231,183
Called up share capital
10,000
10,000
Profit and loss account
172,420
221,183
Shareholders' funds
182,420
231,183
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 26 May 2026 and were signed on its behalf by
K L Aspinall Nessling
Director
Company Registration No. 03688753
Lisoma International Limited
Notes to the Accounts
for the year ended 31 December 2025
Lisoma International Limited is a private company, limited by shares, registered in England and Wales, registration number 03688753. The registered office is 14 Whyke Road, Chichester, PO19 7AN, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Revenue, described as turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes
Goodwill, being the amount paid in connection with the acquisition of a business in 2001, is being amortised evenly over its estimated useful life of twenty years.
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% on reducing balance
4
Intangible fixed assets
Goodwill
At 31 December 2025
34,946
At 31 December 2025
34,946
Lisoma International Limited
Notes to the Accounts
for the year ended 31 December 2025
5
Tangible fixed assets
Plant & machinery
Amounts falling due within one year
Trade debtors
112,368
34,283
Amounts due from group undertakings etc.
404,818
75,448
Accrued income and prepayments
10,028
5,358
7
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
81,548
18,100
Trade creditors
33,262
36,002
Amounts owed to group undertakings and other participating interests
4,972
6,812
Taxes and social security
53
53
The controlling party is BioActive Pharma Ltd
9
Average number of employees
During the year the average number of employees was 0 (2024: 0).